-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vum7r6UafouEeD2mWETRk9ExJ99Cjk8szMdXnZIe6Juh1FZJzx8gk3PDxKKpyfzQ ZbqBNcggeGiaFIKx55+pDw== 0001209191-09-021063.txt : 20090409 0001209191-09-021063.hdr.sgml : 20090409 20090409101932 ACCESSION NUMBER: 0001209191-09-021063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090407 FILED AS OF DATE: 20090409 DATE AS OF CHANGE: 20090409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abovitz Rony A CENTRAL INDEX KEY: 0001424206 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33966 FILM NUMBER: 09741422 MAIL ADDRESS: STREET 1: C/O MAKO SURGICAL CORP. STREET 2: 2555 DAVIE ROAD CITY: FORT LAUDERDALE STATE: FL ZIP: 33317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAKO Surgical Corp. CENTRAL INDEX KEY: 0001411861 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 201901148 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2555 DAVIE ROAD CITY: FT. LAUDERDALE STATE: FL ZIP: 33317 BUSINESS PHONE: 954-927-2044 MAIL ADDRESS: STREET 1: 2555 DAVIE ROAD CITY: FT. LAUDERDALE STATE: FL ZIP: 33317 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-04-07 0 0001411861 MAKO Surgical Corp. MAKO 0001424206 Abovitz Rony A C/O MAKO SURGICAL CORP. 2555 DAVIE ROAD FT. LAUDERDALE FL 33317 0 1 0 0 SVP, Chief Technology Officer Common Stock 2009-04-07 4 M 0 1745 0.6666 A 1745 D Common Stock 2009-04-07 4 S 0 1745 7.6467 D 0 D Employee Stock Option (Right to Buy) 0.6666 2009-04-07 4 M 0 1745 0.00 D 2004-12-16 2014-12-16 Common Stock 1745 9867 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2008. As previously reported, the plan terminates on the earlier of (i) the sale of all 60,000 shares under the plan and (ii) October 31, 2009. Taking into account the sales reported on this Form 4, all 60,000 shares under the plan have been sold; accordingly, the plan has been terminated. The price in column 4 is a weighted average price per share. The prices actually paid ranged from $7.40 to $7.80 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. /s/ Menashe R. Frank, attorney in fact 2009-04-09 -----END PRIVACY-ENHANCED MESSAGE-----